Aghion Daniel has filed 7 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 30000 shares of ORAMED PHARMACEUTICALS INC. ($ORMP) on December 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Aghion Daniel | Director | A | Common Stock | 30000 | $0.00 | 107,191.0000 | 42,774,504 | 38.86% | 0.07% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Aghion Daniel | Director | A | Common Stock | 6250 | $0.00 | 113,441.0000 | 42,774,504 | 5.83% | 0.01% |
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Aghion Daniel | Director | A | Common Stock | 30000 | $0.00 | 68,820.0000 | 41,228,782 | 77.28% | 0.07% |
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Aghion Daniel | Director | A | Common Stock | 8371 | $0.00 | 77,191.0000 | 41,228,782 | 12.16% | 0.02% |
| Jan. 30, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Aghion Daniel | Director | A | Common Stock | 3750 | $0.00 | 38,820.0000 | 40,566,901 | 10.69% | 0.01% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Aghion Daniel | Director | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 40,566,901 | 9999.99% | 0.07% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Aghion Daniel | Director | A | Common Stock | 5070 | $0.00 | 35,070.0000 | 40,566,901 | 16.90% | 0.01% |